Table 3 Comparison of in vitro uptake of 18F-FMISO between LoVo and HT29 cells (%).

From: Noninvasive evaluation of 18F-FDG/18F-FMISO-based Micro PET in monitoring hepatic metastasis of colorectal cancer

 

LoVo

HT29

P

30 min

0.87 ± 0.05

0.78 ± 0.06

0.049

60 min

1.54 ± 0.08

0.96 ± 0.05

0.000

120 min

2.06 ± 0.549

1.31 ± 0.168

0.087

240 min

4.23 ± 0.128

3.34 ± 0.181

0.002

  1. RMANOVA (time*groups), P = 0.001; t test (LoVo vs HT29), P = 0.049, 0.000, 0.002 at 30, 60, 240 min, respectively.
Back to article page